A review of the molecular mechanisms underlying the development and progression of cardiac remodeling

L Schirone, M Forte, S Palmerio, D Yee… - Oxidative medicine …, 2017 - Wiley Online Library
Pathological molecular mechanisms involved in myocardial remodeling contribute to alter
the existing structure of the heart, leading to cardiac dysfunction. Among the complex …

MicroRNAs as biomarkers for clinical studies

IP Pogribny - Experimental Biology and Medicine, 2018 - journals.sagepub.com
The development of better diagnostic and prognostic non-invasive biomarkers holds an
enormous potential to improve the ability to diagnose and individualize treatment of a great …

Circulatory miR-133b and miR-21 as novel biomarkers in early prediction and diagnosis of coronary artery disease

D Kumar, R Narang, V Sreenivas, V Rastogi, J Bhatia… - Genes, 2020 - mdpi.com
While coronary artery disease (CAD) has become a major threat worldwide, the timely
biomarker-based early diagnosis of CAD remains a major unmet clinical challenge. We …

microRNA in cardiovascular aging and age-related cardiovascular diseases

C de Lucia, K Komici, G Borghetti… - Frontiers in …, 2017 - frontiersin.org
Over the last decades, life expectancy has significantly increased although several chronic
diseases persist in the population, with aging as the leading risk factor. Despite …

Va** cardiovascular health risks: an updated umbrella review

M Peruzzi, G Biondi-Zoccai, R Carnevale… - Current emergency and …, 2020 - Springer
Abstract Purpose of Review Modified risk products (MRP) such as electronic va**
cigarettes (EVC) and heat-not-burn cigarettes (HNBC) are alternatives to traditional …

MicroRNAs in acute ST elevation myocardial infarction—a new tool for diagnosis and prognosis: therapeutic implications

AI Scărlătescu, MM Micheu, NM Popa-Fotea… - International journal of …, 2021 - mdpi.com
Despite diagnostic and therapeutic advances, coronary artery disease and especially its
extreme manifestation, ST elevation myocardial infarction (STEMI), remain the leading …

MicroRNAs as a potential biomarker in the diagnosis of cardiovascular diseases

D Kramna, P Riedlova, V Jirik - Medicina, 2023 - mdpi.com
Cardiovascular diseases (CVD) are the leading cause of death in most developed countries.
MicroRNAs (miRNAs) are highly investigated molecules not only in CVD but also in other …

Circulating miR‐133a‐3p and miR‐451a as potential biomarkers for diagnosis of coronary artery disease

R Andiappan, R Govindan, T Ramasamy… - Acta …, 2024 - Taylor & Francis
Background Coronary artery disease (CAD) remains the leading cause of mortality and
morbidity around the world. Despite significant progress in the diagnosis and treatment of …

Long-term sports practice and atrial fibrillation: an updated review of a complex relationship

M Petrungaro, L Fusco, E Cavarretta, A Scarà… - Journal of …, 2023 - mdpi.com
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice, and it is
an enormous burden worldwide because of its high morbidity, disability and mortality. It is …

MicroRNA profiling as a novel diagnostic tool for identification of patients with inflammatory and/or virally induced cardiomyopathies

G Aleshcheva, H Pietsch, F Escher… - ESC Heart …, 2021 - Wiley Online Library
Aims MicroRNAs (miRNAs) might be used as prospective biomarkers for the identification of
unexplained heart failure caused by a viral and/or inflammatory process. The aim of this …